Homero Augusto de Miranda1, Marcelo Cavalcante Costa1, Maria Auxiliadora Monteiro Frazão1, Natália Simão2, Sandra Franchischini3, Darius M Moshfeghi4. 1. Ophthalmic Telemedicine Santa Casa of São Paulo, São Paulo, Brazil. 2. Department of Ophthalmology, University of São Paulo, São Paulo, Brazil. 3. Department of Ophthalmology, University of Santo Amaro, São Paulo, Brazil. 4. Department of Ophthalmology, Horngren Family Vitreoretinal Center, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California. Electronic address: dariusm@stanford.edu.
Abstract
PURPOSE: To describe the ocular findings of 3 cases of suspected congenital Zika viral infection with microcephaly and maculopathy. DESIGN: Retrospective, consecutive case series. PARTICIPANTS: Three male infants born in northern Brazil whose mothers demonstrated a viral syndrome during the first trimester and who subsequently were born with microcephaly. METHODS: Observational report of macular findings. MAIN OUTCOME MEASURES: Continued observation. RESULTS: Three male infants were born with microcephaly to mothers who had a viral syndrome during the first trimester of gestation in an area that subsequently has demonstrated epidemic Zika infection, a flavivirus related to Dengue. Ocular examination was performed. All 6 eyes demonstrated a pigmentary maculopathy ranging from mild to pronounced. In 4 eyes, well-delineated macular chorioretinal atrophy with a hyperpigmented ring developed. Three eyes demonstrated vascular tortuosity and 2 eyes demonstrated a pronounced early termination of the retinal vasculature on photographic evaluation. Two eyes demonstrated a washed out peripheral retina with a hypolucent spot. One eye had scattered subretinal hemorrhages external to the macula. Finally, 1 eye demonstrated peripheral pigmentary changes and clustered atrophic lesions resembling grouped congenital albinotic spots (polar bear tracks). CONCLUSIONS: Zika virus has been linked to microcephaly in children of mothers with a viral syndrome during the first trimester of pregnancy. Ocular findings previously described a pigmentary retinopathy and atrophy that now can be expanded to include torpedo maculopathy, vascular changes, and hemorrhagic retinopathy. Ophthalmologic screening guidelines need to be defined to determine which children would benefit from newborn screening in affected regions.
PURPOSE: To describe the ocular findings of 3 cases of suspected congenital Zika viral infection with microcephaly and maculopathy. DESIGN: Retrospective, consecutive case series. PARTICIPANTS: Three male infants born in northern Brazil whose mothers demonstrated a viral syndrome during the first trimester and who subsequently were born with microcephaly. METHODS: Observational report of macular findings. MAIN OUTCOME MEASURES: Continued observation. RESULTS: Three male infants were born with microcephaly to mothers who had a viral syndrome during the first trimester of gestation in an area that subsequently has demonstrated epidemic Zika infection, a flavivirus related to Dengue. Ocular examination was performed. All 6 eyes demonstrated a pigmentary maculopathy ranging from mild to pronounced. In 4 eyes, well-delineated macular chorioretinal atrophy with a hyperpigmented ring developed. Three eyes demonstrated vascular tortuosity and 2 eyes demonstrated a pronounced early termination of the retinal vasculature on photographic evaluation. Two eyes demonstrated a washed out peripheral retina with a hypolucent spot. One eye had scattered subretinal hemorrhages external to the macula. Finally, 1 eye demonstrated peripheral pigmentary changes and clustered atrophic lesions resembling grouped congenital albinotic spots (polar bear tracks). CONCLUSIONS:Zika virus has been linked to microcephaly in children of mothers with a viral syndrome during the first trimester of pregnancy. Ocular findings previously described a pigmentary retinopathy and atrophy that now can be expanded to include torpedo maculopathy, vascular changes, and hemorrhagic retinopathy. Ophthalmologic screening guidelines need to be defined to determine which children would benefit from newborn screening in affected regions.
Authors: Andrea A Zin; Irena Tsui; Julia Rossetto; Zilton Vasconcelos; Kristina Adachi; Stephanie Valderramos; Umme-Aiman Halai; Marcos Vinicius da Silva Pone; Sheila Moura Pone; Joel Carlos Barros Silveira Filho; Mitsue S Aibe; Ana Carolina C da Costa; Olivia A Zin; Rubens Belfort; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: JAMA Pediatr Date: 2017-09-01 Impact factor: 16.193
Authors: Gustavo Garcia; Sayan Paul; Sara Beshara; V Krishnan Ramanujan; Arunachalam Ramaiah; Karin Nielsen-Saines; Melody M H Li; Samuel W French; Kouki Morizono; Ashok Kumar; Vaithilingaraja Arumugaswami Journal: Am J Pathol Date: 2020-02-05 Impact factor: 4.307
Authors: Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen Journal: JAMA Pediatr Date: 2017-03-01 Impact factor: 16.193
Authors: Jonathan J Miner; Abdoulaye Sene; Justin M Richner; Amber M Smith; Andrea Santeford; Norimitsu Ban; James Weger-Lucarelli; Francesca Manzella; Claudia Rückert; Jennifer Govero; Kevin K Noguchi; Gregory D Ebel; Michael S Diamond; Rajendra S Apte Journal: Cell Rep Date: 2016-09-06 Impact factor: 9.423